Ignite Creation Date:
2024-05-05 @ 9:36 PM
Last Modification Date:
2024-10-26 @ 10:06 AM
Study NCT ID:
NCT00921375
Status:
COMPLETED
Last Update Posted:
2014-12-12
First Post:
2009-05-23
Brief Title:
Safety and Efficacy of TULY Rasburicase in Prevention and Treatment of Malignancy-associated Hyperuricemia
Sponsor:
Organization:
Virchow Group
Study Design
Study Type:
INTERVENTIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
None
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
None
Bio Spec Description:
None
Enrollment Count:
100
Enrollment Type:
ACTUAL
Design Primary Purpose:
Design Masking:
Phases:
| Name |
|---|
| PHASE3 |
Observational Models:
Time Perspective List:
Who Masked List: